Skip to main content
Erschienen in: AIDS and Behavior 2/2024

12.12.2023 | Original Paper

Efficacy of Two Evidence-Based Alcohol Consumption Interventions on Positive, Negative, and Neutral Days Among Hazardous Alcohol Users Living with HIV in Vietnam

verfasst von: Jane S. Chen, Heidi E. Hutton, Ha Viet Tran, Vu Nguyen Quang, Minh X. Nguyen, Teerada Sripaipan, David W. Dowdy, Carl A. Latkin, Geetanjali Chander, Constantine Frangakis, Vivian F. Go

Erschienen in: AIDS and Behavior | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Social events and stressful settings can be catalysts for alcohol consumption. Motivational enhancement therapy (MET) and cognitive behavioral therapy (CBT) are widely used in alcohol interventions. We assessed how alcohol consumption varied across three types of days (positive/social, negative/stressful, and neutral) among hazardous alcohol users living with HIV in Vietnam. We further evaluated how those consumption patterns changed after two MET/CBT alcohol reduction interventions versus the standard of care (SOC). The ‘combined’ intervention offered 6 individual sessions and 3 group sessions; the ‘brief’ intervention offered 2 individual sessions and 2 phone calls. A 30-day timeline follow-back was administered at study visits, detailing daily drinks and events. Days were categorized as neutral, positive/social, or negative/stressful; negative binomial models and generalized estimating equations were used to estimate drinks consumed by type of day at baseline and 12 months. Prior to intervention, more drinks were consumed on positive/social days (5.2 drinks; 95% Confidence Interval [CI]:4.8, 5.7) than negative/stressful (1.5; 95% CI:1.3, 1.9) and neutral days (2.2; 95% CI: 1.9, 2.5). After the brief intervention, drinks consumed decreased on neutral days (ratio: 0.5: 95% CI: 0.4, 0.7). After the combined intervention, drinks consumed decreased on neutral days (ratio: 0.4; 95% CI: 0.3, 0.6), positive/social days (ratio: 0.6; 95% CI: 0.5, 0.7) and negative/stressful days (ratio: 0.3; 95% CI: 0.2, 0.6). No reductions in consumption were observed in the SOC group. Social/positive days had the highest alcohol consumption prior to intervention, and the combined intervention showed the greatest decrease in consumption on those days.

Clinical Trial Registration

The study is registered at clinicaltrials.gov (NCT02720237).
Literatur
1.
Zurück zum Zitat Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, et al. A meta-analysis of cognitive-behavioral therapy for alcohol or other Drug Use Disorders: treatment efficacy by contrast condition. J Consult Clin Psychol. 2019;87(12):1093–105.CrossRefPubMedPubMedCentral Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, et al. A meta-analysis of cognitive-behavioral therapy for alcohol or other Drug Use Disorders: treatment efficacy by contrast condition. J Consult Clin Psychol. 2019;87(12):1093–105.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat DiClemente CC, Bellino LE, Neavins TM. Motivation for change and Alcoholism treatment. Alcohol Res Health. 1999;23(2):86–92.PubMedPubMedCentral DiClemente CC, Bellino LE, Neavins TM. Motivation for change and Alcoholism treatment. Alcohol Res Health. 1999;23(2):86–92.PubMedPubMedCentral
3.
Zurück zum Zitat Longabaugh R, Morgenstern J. Cognitive-behavioral coping-skills therapy for alcohol dependence. Current status and future directions. Alcohol Res Health. 1999;23(2):78–85.PubMedPubMedCentral Longabaugh R, Morgenstern J. Cognitive-behavioral coping-skills therapy for alcohol dependence. Current status and future directions. Alcohol Res Health. 1999;23(2):78–85.PubMedPubMedCentral
4.
Zurück zum Zitat Morgenstern J, Longabaugh R. Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction. 2000;95(10):1475–90.CrossRefPubMed Morgenstern J, Longabaugh R. Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction. 2000;95(10):1475–90.CrossRefPubMed
5.
Zurück zum Zitat Hutton HE, Lancaster KE, Zuskov D, Mai NVT, Quynh BX, Chander G, et al. Cultural Adaptation of 2 Evidence-Based Alcohol Interventions for Antiretroviral Treatment Clinic Patients in Vietnam. J Int Assoc Provid AIDS Care. 2019;18:2325958219854368.CrossRefPubMedPubMedCentral Hutton HE, Lancaster KE, Zuskov D, Mai NVT, Quynh BX, Chander G, et al. Cultural Adaptation of 2 Evidence-Based Alcohol Interventions for Antiretroviral Treatment Clinic Patients in Vietnam. J Int Assoc Provid AIDS Care. 2019;18:2325958219854368.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Kadden RM. Behavioral and cognitive-behavioral treatments for Alcoholism: research opportunities. Addict Behav. 2001;26(4):489–507.CrossRefPubMed Kadden RM. Behavioral and cognitive-behavioral treatments for Alcoholism: research opportunities. Addict Behav. 2001;26(4):489–507.CrossRefPubMed
7.
Zurück zum Zitat Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202.CrossRefPubMedPubMedCentral Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM. Associations between Alcohol Use Disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS. BMC Public Health. 2014;14:27.CrossRefPubMedPubMedCentral Tran BX, Nguyen LT, Do CD, Nguyen QL, Maher RM. Associations between Alcohol Use Disorders and adherence to antiretroviral treatment and quality of life amongst people living with HIV/AIDS. BMC Public Health. 2014;14:27.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of Alcohol Use Disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93.CrossRefPubMedPubMedCentral Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of Alcohol Use Disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV Infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRefPubMedPubMedCentral Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV Infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Nguyen MX, Hershow RB, Blackburn NA, Bui QX, Latkin CA, Hutton H, et al. I refused to drink but they still forced me: a mixed-methods approach to understanding the pathways to reduce alcohol use among Vietnamese people with HIV. Soc Sci Med. 2022;301:114902.CrossRefPubMedPubMedCentral Nguyen MX, Hershow RB, Blackburn NA, Bui QX, Latkin CA, Hutton H, et al. I refused to drink but they still forced me: a mixed-methods approach to understanding the pathways to reduce alcohol use among Vietnamese people with HIV. Soc Sci Med. 2022;301:114902.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Go VF, Hutton HE, Ha TV, Chander G, Latkin CA, Mai NVT, et al. Effect of 2 Integrated Interventions on Alcohol Abstinence and viral suppression among Vietnamese adults with Hazardous Alcohol Use and HIV: a Randomized Clinical Trial. JAMA Netw Open. 2020;3(9):e2017115.CrossRefPubMedPubMedCentral Go VF, Hutton HE, Ha TV, Chander G, Latkin CA, Mai NVT, et al. Effect of 2 Integrated Interventions on Alcohol Abstinence and viral suppression among Vietnamese adults with Hazardous Alcohol Use and HIV: a Randomized Clinical Trial. JAMA Netw Open. 2020;3(9):e2017115.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Hershow RB, Zuskov DS, Vu Tuyet Mai N, Chander G, Hutton HE, Latkin C, et al. [Drinking is] like a rule that you can’t Break: Perceived barriers and facilitators to reduce Alcohol Use and improve antiretroviral treatment adherence among people living with HIV and Alcohol Use Disorder in Vietnam. Subst Use Misuse. 2018;53(7):1084–92.CrossRefPubMedPubMedCentral Hershow RB, Zuskov DS, Vu Tuyet Mai N, Chander G, Hutton HE, Latkin C, et al. [Drinking is] like a rule that you can’t Break: Perceived barriers and facilitators to reduce Alcohol Use and improve antiretroviral treatment adherence among people living with HIV and Alcohol Use Disorder in Vietnam. Subst Use Misuse. 2018;53(7):1084–92.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Miller WR. S R. Motivational interviewing: Helping people Change. New York, NY: Guilford Press; 2012. Miller WR. S R. Motivational interviewing: Helping people Change. New York, NY: Guilford Press; 2012.
15.
Zurück zum Zitat Parsons JT, Rosof E, Punzalan JC, Di Maria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDS. 2005;19(1):31–9.CrossRefPubMed Parsons JT, Rosof E, Punzalan JC, Di Maria L. Integration of motivational interviewing and cognitive behavioral therapy to improve HIV medication adherence and reduce substance use among HIV-positive men and women: results of a pilot project. AIDS Patient Care STDS. 2005;19(1):31–9.CrossRefPubMed
16.
Zurück zum Zitat Smedslund G, Berg RC, Hammerstrøm KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev. 2011;2011(5):Cd008063.PubMedPubMedCentral Smedslund G, Berg RC, Hammerstrøm KT, Steiro A, Leiknes KA, Dahl HM, et al. Motivational interviewing for substance abuse. Cochrane Database Syst Rev. 2011;2011(5):Cd008063.PubMedPubMedCentral
17.
Zurück zum Zitat Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70(4):516–27.CrossRefPubMedPubMedCentral Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70(4):516–27.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Lancaster KE, Hetrick A, Sripaipan T, Ha TV, Hutton HE, Chander G, et al. Alcohol abstinence stigma and alcohol use among HIV patients in Thai Nguyen, Vietnam. PLoS ONE. 2020;15(9):e0239330.CrossRefPubMedPubMedCentral Lancaster KE, Hetrick A, Sripaipan T, Ha TV, Hutton HE, Chander G, et al. Alcohol abstinence stigma and alcohol use among HIV patients in Thai Nguyen, Vietnam. PLoS ONE. 2020;15(9):e0239330.CrossRefPubMedPubMedCentral
Metadaten
Titel
Efficacy of Two Evidence-Based Alcohol Consumption Interventions on Positive, Negative, and Neutral Days Among Hazardous Alcohol Users Living with HIV in Vietnam
verfasst von
Jane S. Chen
Heidi E. Hutton
Ha Viet Tran
Vu Nguyen Quang
Minh X. Nguyen
Teerada Sripaipan
David W. Dowdy
Carl A. Latkin
Geetanjali Chander
Constantine Frangakis
Vivian F. Go
Publikationsdatum
12.12.2023
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 2/2024
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-04234-6

Weitere Artikel der Ausgabe 2/2024

AIDS and Behavior 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.